circRNA basic information
circBase ID: -
Name: hsa_circ_SNX6
Synonym: circSNX6
Host Gene: SNX6
Genomic location(hg19): -
Genomic location(hg38): -
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0007256
MONDO name: hepatocellular carcinoma
Disease details: hepatocellular carcinoma / HCC
Disease DO ID:
684, 686
Disease MeSH ID:
D006528
Disease NCIt ID:
C3099
Disease ICD11 ID:
1294035808
Disease OMIM ID:
114550
Species: Human
Species details: Homo sapiens
Tissue specimen:

HCC tissues; adjacent normal tissues

Cell lines:

HL-7702; HCCLM3; MHCC97-H; MHCC97-L; Huh-7; HepG2; Hep3B

In vivo animal model:

-

circRNA-disease information
Expression pattern:
UP
Associated gene: -
Associated microRNA: -
Biological function: Significantly upregulated in HCC tissues; no diagnostic value or functional assay result was reported for circSNX6.
Molecular mechanism: Potential circRNA-miRNA-mRNA network predicted by bioinformatics; no specific validated mechanism was reported.
Biological pathway or process:

ceRNA regulation (other); other pathway/process (other)

Detected method:
Q
S
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; RNase R Treatment; Sanger Sequencing; RT-qPCR; RNA-seq; Clinical Sample Validation; ROC Analysis; Bioinformatics Analysis

Clinical significance:

No diagnostic discrimination of HCC tissue from normal tissue was observed; expression levels were not correlated with clinicopathological characteristics.

Description:

circSNX6 was significantly upregulated in HCC tissues after RNA-seq screening and qRT-PCR validation. However, the study did not identify diagnostic utility, clinicopathological association, functional effects, or a validated molecular mechanism for circSNX6.

Confidence score:

0.6841

Other information
Title:

CircRNA profiling identifies circRNF180 as a tumor suppressor in hepatocellular carcinoma.

Journal: Epigenomics
Published: 2021
PubMed ID: 33683141
Study type:

combined biological and clinical study

Data availability: PRJNA663845; www.futuremedicine.com/doi/suppl/10.2217/epi-2020-0385
Code availability: -